Dentium (A145720) Q2 2024 earnings summary

Executive summary

• Achieved continued growth in sales and operating profit over the past five years, with a strong presence in both domestic and international dental implant markets.

• Specializes in dental implants and digital dental equipment, with 88% of sales from implants and 77% of revenue from overseas markets.

• Holds the second-largest market share in Korea and is expanding globally with 24 overseas subsidiaries.

• Focused on expanding digital dentistry solutions and entering new overseas markets for sustainable growth.

• Added new business lines in interior construction for dental clinics and hydrogen fuel cell energy, aiming for future growth.

Financial highlights

• 2023 revenue reached KRW 393.2 billion, up from KRW 355.9 billion in 2022.

• 2024 first half revenue was KRW 194.4 billion, with net income of KRW 37.3 billion.

• Operating income for 2023 was KRW 138.3 billion, compared to KRW 125.7 billion in 2022.

• Basic EPS for H1 2024: KRW 4,331; cash and equivalents at period end: KRW 86.6 billion.

• Gross margin remains strong; R&D expense ratio at 2.4% of sales.

Outlook and guidance

• Targeting global top 3 position by 2030 through expansion in advanced markets and economies of scale.

• Aims for over 20% annual sales growth from 2026 to 2028, driven by new product launches and global production integration.

• Plans to strengthen domestic market position and expand in China, Asia, and the Middle East.

• Focus on digital dentistry and new business lines to drive future growth.